ERK inhibitor Ulixertinib, Purity ≥98%

Synonym: Ulixertinib; 869886-67-9; VRT752271; BVD-523; Ulixertinib [INN]; Ulixertinib (BVD-523); UNII-16ZDH50O1U; ERK inhibitor

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Ulixertinib, soluble in DMSO and ethanol and insoluble in water, exhibits potent inhibition of ERK kinase. It targets ERK1 and ERK2.

Molecular Weight

433.3

Molecular Formula

C₂₁H₂₂Cl₂N₄O₂

Targets

ERK1; ERK2: <0.3 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 80 mg/mL (184.61 mM); Water: Insoluble; Ethanol: 14 mg/mL (32.3 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Ulixertinib can be used to study the impacts of selective ERK1/2 inhibition in cancer models.

Storage

Store at -20ºC.